Pharm

Nevirapine

search

Nevirapine, Viramune, NVP

  • See Also
  1. Anti-Retroviral Therapy
  2. Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
  • Class
  1. Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
  • Efficacy
  1. Good benefit in combination with 2 Nucleosides
  • Dosing
  1. Start: 200 mg PO qd for 14 days
  2. If no rash, increase dose to 200 mg PO bid
  • Adverse effects
  1. See NNRTI for class related adverse effects
  2. Severe hepatoxicity and liver failure risk if pre-treatment CD4 >250 in men or >400 in women
  • References
  1. (2009) Treat Guidel Med Lett 7(78): 11-22 [PubMed]